| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/20/2001 | US20010022965 Colloidal dispersion |
| 09/20/2001 | US20010022964 Fast dissolving orally consumable films |
| 09/20/2001 | DE10013312A1 Production of oily suspensions of water soluble vitamins comprises milling of vitamins in oil or dry milling and suspension in oil |
| 09/20/2001 | DE10013289A1 Storage-stable formulations containing diuretic torasemide, are solids or semi-solids containing the active agent in non-crystalline form, e.g. as solid solution in vinyl pyrrolidone polymer matrix |
| 09/20/2001 | DE10013122A1 New anaesthetic for epidural administration comprises liposomes containing a lipophilic gas, especially xenon |
| 09/20/2001 | DE10013030A1 Formulation for treating ulcerative colitis, comprising active agent, e.g. 5-aminosalicylic acid or prednisone, coated with acrylic copolymer to provide delayed release at high pH in the colon |
| 09/20/2001 | DE10013029A1 Multilayer formulation for controlled drug release in colon, comprising drug-containing core having inner and outer coatings of acrylic copolymers with quaternary ammonium and anionic groups respectively |
| 09/20/2001 | DE10012569A1 Hard gelatin capsule formulation containing retarded-release plant extract, as free-flowing powder filling obtained by film-coating compacted plant extract |
| 09/20/2001 | DE10012555A1 Composition for rapid release of corticoid drugs after delay period, useful for drug delivery during the night, e.g. for preventing asthma, or for delivery to colon for treating inflammatory bowel disease |
| 09/20/2001 | DE10012063A1 Soft plasticizer-free capsules for use in pharmaceuticals, cosmetics, detergents or plant protectants are made from a polymers obtained by polymerizing a vinyl ester in presence of a polyether substrate |
| 09/20/2001 | DE10012026A1 Stable aqueous gel containing polyhexamethylene biguanide, glycerol and hydroxyethyl cellulose, useful e.g. as washing or shower gel having decontaminant action or for covering wounds, |
| 09/20/2001 | DE10011447A1 New stable (meth)acrylate copolymer emulsion containing nonionic emulsifier, useful as coating and binding agent for medicaments, is not subject to emulsifier crystallization |
| 09/20/2001 | DE10011344A1 Pressurized gas foam spray containing essential oil, useful medicinally or cosmetically for treating skin diseases, is stable, easily applied and hypoallergenic |
| 09/20/2001 | DE10006779A1 Appetite reducing pads, impregnated with bitter principles for continuous release to the taste buds on insertion in the buccal cavity, useful in reduction of body weight |
| 09/20/2001 | CA2411732A1 Crystalline base of citalopram |
| 09/20/2001 | CA2403241A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 09/20/2001 | CA2403233A1 Glycogen phosphorylase inhibitor |
| 09/20/2001 | CA2403063A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/20/2001 | CA2402865A1 Opioid formulations |
| 09/20/2001 | CA2402716A1 Hard gelatine capsules containing sustained-release plant extracts and method for production thereof |
| 09/20/2001 | CA2402547A1 Digestable chewing gum |
| 09/20/2001 | CA2402413A1 Compositions and methods for affecting osteogenesis |
| 09/20/2001 | CA2402331A1 Liquid crystalline polymers |
| 09/20/2001 | CA2402296A1 Intradermal-penetration agents for topical local anesthetic administration |
| 09/20/2001 | CA2402294A1 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | CA2402122A1 D-enantiomer of dfmo and methods of use therefor |
| 09/20/2001 | CA2401270A1 Method for labeling individual cells |
| 09/20/2001 | CA2378464A1 Fading inhibitors |
| 09/20/2001 | CA2373237A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 09/19/2001 | EP1133989A2 Polymer compositions for use in therapy |
| 09/19/2001 | EP1133985A1 Pressure-sensitive adhesive gel composition for iontophoresis and apparatus therefor |
| 09/19/2001 | EP1133984A1 Solid preparation containing low-substituted hydroxypropyl cellulose and production process thereof |
| 09/19/2001 | EP1133555A2 Pharmaceutical factor vii preparation |
| 09/19/2001 | EP1133520A2 Compositions and methods using lactadherin or variants thereof |
| 09/19/2001 | EP1133476A1 Iminoguanidine derivatives, preparation method, use as medicines |
| 09/19/2001 | EP1133325A1 Coating useful as a dispenser of an active ingredient on dressings and bandages |
| 09/19/2001 | EP1133322A1 Improved uncomplexed cyclodextrin compositions for odor control |
| 09/19/2001 | EP1133316A1 Formulation of adenovirus for gene therapy |
| 09/19/2001 | EP1133313A2 Calcitonin for the modulation of sperm function |
| 09/19/2001 | EP1133301A1 Anti-asthmatic combinations comprising surface active phospholipids |
| 09/19/2001 | EP1133300A1 Desmethylolanzapine compositions and methods |
| 09/19/2001 | EP1133299A1 2-hydroxymethylolanzapine compositions and methods |
| 09/19/2001 | EP1133298A1 Compositions comprising cefuroxime axetil |
| 09/19/2001 | EP1133286A1 Solid lipidic nanospheres suitable to a fast internalization into cells |
| 09/19/2001 | EP1133285A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 09/19/2001 | EP1133284A1 New process |
| 09/19/2001 | EP1133283A1 A method of producing drug particles |
| 09/19/2001 | EP1133282A1 Taste masking rapid release coating system |
| 09/19/2001 | EP1133281A1 Dispersible phospholipid stabilized microparticles |
| 09/19/2001 | EP1133280A1 Method of preparing stable suspensions of insoluble microparticles |
| 09/19/2001 | EP1133279A1 Method of producing vitamin powders |
| 09/19/2001 | EP1133278A2 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 09/19/2001 | EP1133277A1 Pharmaceutical aerosol composition containing hfa 227 and hfa 134a |
| 09/19/2001 | EP1133271A1 Method of producing solid dosage forms |
| 09/19/2001 | EP1133269A1 Controlled release system for delivering therapeutic agents into the inner ear |
| 09/19/2001 | EP0918536B1 Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 09/19/2001 | EP0912162B1 Solid oral anticariogenic composition for cleaning the buccal cavity and teeth, and process for preparing this composition |
| 09/19/2001 | EP0871434B1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 09/19/2001 | EP0871420B1 Triacetin as a transdermal penetration enhancer |
| 09/19/2001 | EP0789584B1 Application of superoxide dismutase in liposomes |
| 09/19/2001 | EP0789540B1 Analyte-controlled liquid delivery device and analyte monitor |
| 09/19/2001 | EP0774896B1 Gel formulation |
| 09/19/2001 | EP0700302B1 Device for treating diabetes mellitus |
| 09/19/2001 | CN2448397Y Slow-released medicinal capsule |
| 09/19/2001 | CN1313873A Polyester analogus of poly-L-Lysine as a soluble, biodegradable gene delivery carrier |
| 09/19/2001 | CN1313786A Method for treating a particulate material with a coating substance and device for implementing such a method |
| 09/19/2001 | CN1313762A Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 09/19/2001 | CN1313761A Exactly divisible tablet |
| 09/19/2001 | CN1313760A Stabilised polyvinylpyrrdidone formulation |
| 09/19/2001 | CN1313759A Fish gelatinous composition for use as an ingredient in tablets |
| 09/19/2001 | CN1313758A Injectable aqueous dispersions of propofol |
| 09/19/2001 | CN1313757A Oral liquid mucoadhesive compositions |
| 09/19/2001 | CN1313756A Oral liquid mucoadhesive compositions |
| 09/19/2001 | CN1313755A Oral mucoadhesive compositions containing gastrointestinal actives |
| 09/19/2001 | CN1313754A Oral liquid mucoadhesive compositions |
| 09/19/2001 | CN1313129A Process for preparing artificially synthetic polypeptide medicines |
| 09/19/2001 | CN1313124A Ointment for treating burn and its preparing process |
| 09/19/2001 | CN1313114A Medicine for treating female dimacteric syndrome and its preparing process |
| 09/19/2001 | CN1313112A Aloe capsule prepared from natural aloe and its preparing process |
| 09/19/2001 | CN1313107A Chinese medicine for prepventing and treating iatrogenic hypercortisonism |
| 09/19/2001 | CN1313105A 'Chinese-medicinal pad' and its preparing process |
| 09/19/2001 | CN1313102A Spray-type gynecological medicine |
| 09/19/2001 | CN1313096A Health-care tonic buccal lozenge |
| 09/19/2001 | CN1313095A Process for preparing plaster to promote circulation of blood and vital energy |
| 09/19/2001 | CN1313089A Iron-supplementing instant effervescent particles and its preparing process |
| 09/19/2001 | CN1313048A Health-care product for reducing blood fat and sugar and delaying sanility |
| 09/19/2001 | CN1071128C Process for preparing injection to treat pulmonary tuberculosis |
| 09/19/2001 | CN1071116C Paroxetine tablets and process to prepare them |
| 09/19/2001 | CN1071114C Injectable mesna solutions |
| 09/19/2001 | CN1071113C Compositions and processes for the sustained release of drugs |
| 09/19/2001 | CA2372450A1 Liquid injectable formulation of disodium pamidronate |
| 09/18/2001 | USRE37382 For diffusing medication (diphenylhydantoin sodium) slowly through a semi-permeable membrane and into the saliva which stimulates nerve, bone, and tissue growth |
| 09/18/2001 | USRE37379 High pressure gas exchanger |
| 09/18/2001 | US6291690 Hydrophobic taxane derivatives |
| 09/18/2001 | US6291639 Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds |
| 09/18/2001 | US6291582 Polymer-protein composites and methods for their preparation and use |
| 09/18/2001 | US6291533 Dietary supplements for each specific blood type |
| 09/18/2001 | US6291528 Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal |
| 09/18/2001 | US6291527 Hydrosoluble salts obtained through a reaction between ketoprofen and glucosamine and/or proline and/or hydroxyproline; useful for antiinflammatory and analgesic treatment of joints and mucous membranes. |
| 09/18/2001 | US6291519 Method of preventing damage to eye tissue |